Article, Clinic, Manufacturing and Provider

Researchers Propose Solutions to Improve GLP-1 RA Access

Physician's Weekly

JUNE 18, 2025

Cost-sharing and education may improve access to GLP-1 therapies for obesity, but systemic barriers remain, requiring broader policy and clinical reforms. Other Persistent Barriers & Potential Solutions In another article not presented at the meeting, Stephanie W. They published their insights in Nature Medicine.

Healthcare Professional

Healthcare Professional Insurance Manufacturing Healthcare

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

JUNE 17, 2025

Artificial intelligence Already, dentists employ software to get insights into clinical decision-making, but AI is changing the face of dentistry, just like it is in many other fields. Smart toothbrush While AI helps dental professionals provide better treatments, smart toothbrushes enable all of us to take better care of our teeth.

Patients

Patients Treatment Plan Healthcare Medical Specialty

Is my Software a Medical Device? Use the Digital Health Policy Navigator

FDA Law

DECEMBER 12, 2022

If you are a manufacturer of implants that go into the human body for the treatment of disease, it’s an easy yes that you are a manufacturer of a medical device. or other similar or related article” which is “intended for use in the diagnosis of disease or other conditions.”

Medical

Medical Manufacturing Electronics Provider

New Draft Guidance Provides Detailed (and Burdensome) Recommendations for Chemical Assessments to Support Medical Device Biocompatibility

FDA Law

NOVEMBER 20, 2024

Chemical characterization can also be useful in evaluating a change to the materials or manufacturing of a device. The draft guidance provides recommendations for collection and reporting of chemical characterization data and discusses the topics of information gathering, test article extraction, chemical analysis, and data reporting.

Provider

Provider Medical Manufacturing Consulting

The National Products Association Challenges FDA’s Interpretation of the Dietary Supplement Exclusionary Clause

FDA Law

SEPTEMBER 18, 2024

However, there is a continuing disagreement between FDA and industry about how that phrase should be read with the phrase “and for which substantial clinical investigations have been institute and for which the existence of such investigations has been made public.”

Manufacturing

Manufacturing Clinic IT Provider

The Chairside Zirconia Revolution: The Evolution of Choice

CDOCS

APRIL 14, 2021

& But, I don’t know if anything has done as much for bringing CAD/CAM into general dentistry offices more than the ability to manufacture zirconia restorations chairside.</span></p> & But, more importantly to me clinically, was the improvement in radiopacity.&

IT

IT Patients Provider Appointment

Hearing Loss in Geriatrics and Palliative Care: A Podcast with Nick Reed and Meg Wallhagen

GeriPal

MAY 5, 2022

Was there any mention about the impact that hearing loss has in communication or what we should do about it in clinical practice? COVID-19, masks, and hearing difficulty: Perspectives of healthcare providers. And he is also a clinical audiologist, which is going to be key for this podcast. I’m guessing not. Transcript.

IT

IT Screening Hospital Clinic

NPA Files Complaint Seeking to Prevent FDA from Applying the Exclusionary Clause Retroactively

FDA Law

DECEMBER 20, 2021

As readers of this blog may know, FDA is not required to provide a substantive response to a CP within a specific time and it may take years before FDA issues a response (In fact, HPM submitted a CP in 2000 to which FDA has yet to respond). FDA merely indicated that it was still considering that issue.

IT

IT Manufacturing Education Clinic

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

GeriPal

MAY 8, 2025

We’ll discuss three recent clinical trials involving patients with serious illness, joined by our guests James Downar , Ali John Zarrabi , and Margaret Ross. Alex 00:33 Our next guest is Margaret Ross, who’s a clinical psychologist and researcher at St. And when that article went to print, it just went ballistic.

Illness

Illness IT Patient-Centered Patients

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

MARCH 2, 2023

I could go on and on, but listen to the podcast instead and for a deeper dive, take a look at the following articles and studies: Gabapentin in the Perioperative setting: Prolonged use of newly prescribed gabapentin after surgery. I understand that it can be a hard place clinically. J Am Geriatr Soc. Alex: Gabapentin for opioids.

Patient-Centered

Patient-Centered IT Healthcare Medical

Advance Care Planning Discussion: Susan Hickman, Sean Morrison, Rebecca Sudore, and Bob Arnold

GeriPal

MARCH 24, 2022

Start by reading this article by Sean Morrison, Diane Meier, and Bob Arnold in JAMA , and this response from Rebecca Sudore, Susan Hickman, and Anne Walling. And I would say too, as a primary care provider, it really doesn’t take that long to ask people about a surrogate decision maker. Eric: Susan. Susan: Yeah.

Illness

Illness IT Healthcare Patient-Centered

Aging and Climate Change: Karl Pillemer, Leslie Wharton, & Ruth McDermott-Levy

GeriPal

DECEMBER 7, 2023

AlexSmithMD Additional links: JAMA paper on clinical research risks, climate change, and health Geriatric medicine in the era of climate change Health Care Without Harm: [link] Practice Green Health: [link] Global Consortium for Climate and Health Education: [link] Transcript Eric: Welcome to the GeriPal podcast.

Healthcare

Healthcare IT Education Community

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

SEPTEMBER 13, 2021

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate. Court of Appeals (again, see our post ).

Manufacturing

Manufacturing Supply Chain Patient-Centered Utilities

Primary Care Digest

Researchers Propose Solutions to Improve GLP-1 RA Access

9 Technologies That Will Shape The Future Of Dentistry

Trending Sources

Is my Software a Medical Device? Use the Digital Health Policy Navigator

New Draft Guidance Provides Detailed (and Burdensome) Recommendations for Chemical Assessments to Support Medical Device Biocompatibility

The National Products Association Challenges FDA’s Interpretation of the Dietary Supplement Exclusionary Clause

The Chairside Zirconia Revolution: The Evolution of Choice

Hearing Loss in Geriatrics and Palliative Care: A Podcast with Nick Reed and Meg Wallhagen

NPA Files Complaint Seeking to Prevent FDA from Applying the Exclusionary Clause Retroactively

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

Advance Care Planning Discussion: Susan Hickman, Sean Morrison, Rebecca Sudore, and Bob Arnold

Aging and Climate Change: Karl Pillemer, Leslie Wharton, & Ruth McDermott-Levy

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

Stay Connected